COVID-19 Updates
Opinion
ID Blog: SARS-CoV-2 – What’s in a name?
From “Wuhan virus” to “novel coronavirus-2019” to “COVID-19 virus” to “SARS-CoV-2,” the process of naming is complex and even risky to public...
News from the FDA/CDC
China’s health authorities release large coronavirus case series
The age distribution shows that most of the cases (87%) occurred in patients aged 30-79 years.
Feature
WHO urges that ‘window of opportunity’ on containing novel coronavirus not be missed
“We must not look back and regret that we failed to take advantage of the window of opportunity that we have now.”
From the Journals
2019-nCoV: Structure, characteristics of key potential therapy target determined
The 2019-nCoV spike protein, critical to infection in coronaviruses, has been sequenced and synthesized and the 3-D structure determined.
Latest News
Doctors look to existing drugs in coronavirus fight
From the Journals
Infection with 2019 novel coronavirus extends to infants
Nine infants with at least one infected family member have tested positive for the 2019 novel coronavirus.
Conference Coverage
As novel coronavirus outbreak evolves, critical care providers need to be prepared
Latest News
ACC issues guidance on cardiac implications of coronavirus
The document provides information on the potential cardiac implications from analog viral respiratory pandemics and offers early clinical guidance...
Opinion
An epidemic of fear and misinformation
Discrimination and fear may do more damage than the 2019 Novel Coronavirus itself.
News from the FDA/CDC
Two new Novel Coronavirus cases confirmed among quarantined U.S. patients
The 14th and 15th cases of 2019-nCoV in the United States both occurred among patients who were under federal quarantine.